Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
Conditions
Generalized Myasthenia Gravis · gMG
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital, Chicago, Illinois, United States
Atrium Health Neurology Specialty Care, Charlotte, North Carolina, United States
University of Virginia (UVA) Health - Developmental Pediatrics Clinic, Charlottesville, Virginia, United States
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
UZ Gent, Ghent, Belgium
Childrens Hospital of Eastern Ontario, Ottawa, Canada
AP-HM- Hôpital de La Timone, Marseille, France
Universitätsklinikum Essen, Essen, Germany
Hadassah Medical Center- Ein Kerem, Jerusalem, Israel
Leids Universitair Medisch Centrum, Leiden, Netherlands
Uniwersyteckie Centrum Kliniczne w Gdansku, Gdansk, Poland
Wielospecjalistyczna Poradnia Lekarska Synapsis, Katowice, Poland
Centralny Szpital Kliniczny - Uniwersyteckie Centrum Kliniczne WUM, Warsaw, Poland
Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain
Great Ormand Street Hospital for Children NHS Foundation Trust - Great Ormond Street Hospital - Pediatric Neurology, London, United Kingdom
Oxford University Hospitals NHS Foundation Trust - John Radcliffe Hospital Children's Hospital, Oxford, United Kingdom